We explored the possibility of using a genetic approach to inhibit integrin-mediated endothelial cell adhesion and survival. We constructed recombinant adenoviruses (Ads) expressing chimeric proteins consisting of the cytoplasmic and transmembrane domains of integrin ␤1 (CH1), ␤3 (CH3) or the ␤1 transmembrane domain alone (CH2) connected to the extracellular domain of L3T4 placed under the control of the CMV promoter (AdCMV) or the endothelial cell specific Tie-1 promoter (AdTie). All constructs were expressed in a dose-and time-dependent manner with over 90% of cells expressing the constructs within 24 h (AdCMVs) or 72 h (AdTies) after infection. Confluent monolayers of HUVEC infected with AdCMVCH1 or AdCMVCH3 detached from the substrate in a time-and dose-dependent manner with over
Introduction
Tumor angiogenesis is a crucial event for tumor progression and metastasis formation. Angiogenic vessels support local tumor expansion by supplying oxygen and nutrients to the proliferating tumor cells and by eliminating their metabolic products. They also play an important role in metastasis formation by favoring the first step of the metastatic process, namely the dissemination of tumor cells into the circulation. 1 Experiments performed using several different tumor mice models have demonstrated that inhibition of tumor angiogenesis can suppress tumor growth. For example, administration of the anti-angiogenic factor endostatin to mice bearing human or murine tumor grafts causes tumor growth arrest and induces tumor regression and dormancy. 2 Inhibition of angiogenesis has been shown to suppress tumor progression in the HaCaT and in the RIP1-Tag2 tumor models, two independent murine models for multistage carcinogenesis.
95% of the cells being detached 2 days (AdCMVs) or 3 to 4 days (AdTies) after infection. Cell detachment was preceded by the disruption of focal adhesions and reorganization of the actin cytoskeleton and was associated with a reduced ligand-binding activity of ␤1, while cell surface density of ␤1 integrins remained unchanged. Detached cells failed to re-adhere to different matrix proteins, without, however, any specificity toward ␤1 or ␤3 integrin-mediated adhesion. Upon detachment, HUVEC rapidly died by apoptosis. These results demonstrate that dominant negative inhibition of integrin function is an effective approach to disrupt endothelial cell adhesion and survival in vitro. Gene Therapy (2000) 7, 1292-1303.
invasion and positioning of angiogenic endothelial cells, as well as for the integrity of the established neovasculature. 5 The main adhesion receptors for the extracellular matrix belong to the integrin family of cell adhesion molecules. 6 Endothelial cells express multiple integrins implicated in angiogenesis, most of which belong to the ␤1 and ␣V subfamilies. ␤1 integrins are essential for the differentiation of ES cells into endothelial cells in vivo and for the formation of a functional vascular network. 7 Among ␤1 integrins, ␣5␤1 is necessary for embryonic blood vessel development (vasculogenesis and angiogenesis) and ␣4␤1 is required for coronary vessel formation and placental development. 8, 9 ␣1␤1 and ␣2␤1 are also implicated in mediating angiogenesis in vivo, as blocking antibodies directed against the ␣1 and the ␣2 integrin subunits markedly inhibited VEGF-driven angiogenesis.
10 ␣6␤1 and ␣2␤1 have been shown to mediate endothelial cell tube formation in vitro. 5, 11 Among the ␣V integrins, ␣V␤3 has been proposed to play a key role in angiogenesis. 11 Although its proposed role in embryonic vascular development 12 has been recently challenged by the report that vasculogenesis and angiogenesis occur in mice lacking the integrin ␣V gene, 13 there is extensive experimental evidence indicating that ␣V␤3 is an important mediator of post-natal angiogenesis. 5, 14 Integrin ␣V␤3 is highly expressed on angiogenic endothelial cells, including tumor endothelial cells, but not, or to a much lower extent, on quiescent endothelial cells.
14,15 ␣V␤3 expression on endothelial cells is induced by angiogenic growth factors or tumors. 16 Inhibition of integrin ␣V␤3 ligation by blocking antibodies or by antagonistic peptides suppresses angiogenesis without affecting the neighboring quiescent vessels, resulting in the inhibition of tumor growth. 14, 17, 18 Several mechanisms have been proposed to explain the anti-angiogenic effect of ␣V␤3 antagonists. ␣V␤3 may directly stimulate survival of angiogenic endothelial cells by suppressing apoptotic stimuli or by enhancing endothelial cell proliferation. Ligation of ␣V␤3 (but not of other integrins) suppresses p53 activity and p21WAF1/CIP1 expression and increases the bcl-2/bax ratio resulting in enhanced cell survival. 19 ␣V␤3, but not ␤1 integrins, associates with VEGFR-2 on endothelial cells, and engagement of ␣V␤3 results in enhanced VEGF-induced VEGFR-2 phosphorylation and endothelial cell proliferation. 20 ␣V␤3 binds to and activates the pre-matrix-metalloproteinase-2 (MMP-2) at sites of cellular invasion, and ␣V␤3-antagonists may inhibit the generation of active MMP-2 resulting in a decreased invasion of angiogenic endothelial cell sprouts into the surrounding tissue. 21, 22 The putative role of ␣V␤3 in human tumor angiogenesis was recently emphasized by the finding that ␣V␤3-dependent endothelial cell adhesion is suppressed upon endothelial cell exposure to high doses of TNF and IFN␥, a cytokine combination that causes disruption of the tumor vasculature and rapid tumor regression in melanoma patients. 23 Integrins are heterodimeric cell surface transmembrane receptors consisting in an ␣ and a ␤ subunit. 6 The ␤ cytoplasmic domain is essential to mediate many of the characteristic functions of integrin receptors: integrin activation ('inside-out signaling'), cell adhesion and spreading, focal adhesion formation, and biochemical signaling ('outside-in' signaling). 24 ␤ subunit cytoplasmic domains are necessary and sufficient to direct integrin localization to focal adhesions. 25, 26 At focal adhesions, the ␤ cytoplasmic domain mediates the anchorage of actin filaments to the plasma membrane and it interacts with cytoskeletal-associated proteins (eg talin, ␣-actinin, paxillin) and with signaling molecules (e.g. FAK, ILK). 24 In fibroblasts, transient high level expression of the isolated ␤1 or ␤3 cytoplasmic domains connected to a transmembrane cell surface reporter molecule (IL-2R␣ chain) results in diminished cell spreading, migration, and ECM (extracellular matrix) assembly. 26, 27 Expression of the isolated ␤1 cytoplasmic domain in embryonic kidney cells 293 from the inducible metallothionein-1 promoter resulted in cell rounding and detachment and blocked integrin-dependent cell adhesion. 28 Based on these data, it was proposed that isolated integrin ␤ cytoplasmic domains have a dominant-negative effect on endogenous integrin function through competitive interactions with cytoplasmic components necessary for integrin function. 26, 28 The work presented here was initiated to test the possibility of disrupting endothelial cell monolayer and inducing endothelial cell death by interfering with integrin function through a dominant negative effect. To this purpose we have generated recombinant adenoviruses (Ad) allowing expression of isolated ␤1 and ␤3 integrin cytoplasmic and transmembrane domains fused to the extracellular domain of the L3T4 molecule and a tail-less L3T4 control protein. Here we report the generation and characterization of the recombinant Ad as well as their Gene Therapy effects on HUVEC (human umbilical vein endothelial cell) adhesion and survival.
Results

Generation of recombinant Ad
To test the effects of isolated ␤-integrin cytoplasmic domains on integrin-dependent endothelial cell adhesion, three recombinant replication-deficient Ad were generated: two expressing chimeric constructs consisting of the human transmembrane and cytoplasmic domains of ␤1 or ␤3 integrin subunit fused to the extracellular domain of the L3T4 (murine CD4) molecule (referred to as CH1 and CH3, respectively), and one expressing the extracellular domain of the L3T4 molecule and the transmembrane domain of ␤1 without the cytoplasmic domain (CH2, control construct). The constructs were placed under the control of the potent ubiquitous CMV promoter or of the human endothelial cell specific Tie-1 promoter. 29, 30 Recombinant Ads were generated by homologous recombination in 293 cells between JM17, a plasmid containing an Ad type-5 dl309 backbone with deletions of E1 and partial deletions of E3 regions, and the shuttle plasmid pXC15, containing a partial Ad-5 sequence and the CH1, CH2 and CH3 constructs. Individual recombinant Ad clones were screened by Southern blotting hybridization for the presence of the promoter and the insert sequences (not shown).
HUVEC infection with recombinant AdCMVCH1, AdCMVCH2 and AdCMVCH3 results in efficient expression of the constructs Confluent HUVEC monolayers were infected with AdCMVCH1, AdCMVCH2, AdCMVCH3, AdCMVLacZ and AdCMVGFP (1 × 10 8 p.f.u./ml) and expression of the constructs was assessed 24 h later by monitoring the amount of the L3T4 molecule at the cell surface by staining with anti-L3T4 mAb (monoclonal antibody) and FACS analysis. HUVEC infection with AdCMVCH1, AdCMVCH2, AdCMVCH3 resulted in homogenous expression of the L3T4 antigen at the cell surface, while infection with AdCMVLacZ or AdCMVGFP had no effect ( Figure 1) . Expression of the control proteins GFP and ␤-gal was confirmed by FACS analysis or by staining the cells with a ␤-gal chromogenic substrate, respectively ( Figure 1 , small insert, and data not shown). We then determined the kinetics of expression of the constructs in a time course experiment. Approximately 25% of the cells expressed significant amounts of L3T4 already 8 h after the start of infection and high levels were observed in 90-97% of the cells after 24 and 48 h (Figure 2a ). HUVEC infection with AdTieCH1, AdTieCH2 and AdTieCH3 also resulted in efficient expression of the constructs, however the kinetic was delayed compared to expression from the CMV promoter. Twenty-four hours after the start of infection only about 50% of the cells showed low levels of L3T4. Expression progressively increased with time and at day 4 after infection more than 90% of the cells displayed high levels of the L3T4 molecule (Figure 2b ). Time course experiments were usually limited to 5 days, since longer exposures resulted in the appearance of some non-specific Ad cytopathic effects.
To establish the relationship between virus titer, efficiency of transduction and the relative level of cell p.f.u./ml) and the relative amount of L3T4 at the cell surface was determined after 48 h. Most cells (50 to 75%) were infected at low viral concentration (1-10 × 10 6 p.f.u./ml), but cell surface level of expression of L3T4 remained low (MFI of 100-200; Figure 2c) . A virus concentration of 50 to 100 × 10 6 p.f.u./ml was required for maximal levels of L3T4 on the majority of the cells (Ͼ80%) (Figure 2d ). Some non-specific toxic effects were observed at concentrations higher than 2 × 10 8 p.f.u./ml. For the AdTie vectors, a minimum of 50 × 10 6 p.f.u./ml were also required for sufficient level of gene expression (data not shown).
In order to confirm the endothelial-cell specificity of the Tie-1 promoter, HUVEC, colon cancer derived HT29 epithelial cells and the melanoma cell lines Me235 and Me315 were exposed to 1 × 10 8 p.f.u./ml of AdCMVCH2 and AdTieCH2 for 3 days. AdCMVCH2 construct was expressed in the four cell types, while AdTieCH2 construct was expressed in HUVEC only ( Figure 3 ). These data confirmed that the Tie-1 promoter is specific for endothelial cells.
From these results, we conclude that HUVEC infection with recombinant Ads containing the CH1, CH2 and CH3 inserts results in efficient expression of the three constructs from the CMV promoter and from the endothelial cell specific Tie-1 promoter. The proportion of expressing cells and the level of expression at the cell surface depend on the concentration of the Ad and on the duration of infection. Similar levels of L3T4 cell surface expression were obtained from the Tie-1 promoter, though with a delay of about 2 days compared to expression from the CMV promoter.
Expression of the CH1 and CH3 constructs causes deadhesion of confluent HUVEC The effect of the expression of the isolated ␤ cytoplasmic domains on endothelial cells was dramatic. When confluent HUVEC monolayers were infected with AdCMVCH1 and AdCMVCH3 constructs, we observed that cells rounded up and detached in dose-dependent manner ( Figure 4 ). HUVEC detachment was complete at Ad doses from 25 to 100 × 10 6 p.f.u./ml, and partial at low doses (6.25-12.5 × 10 6 p.f.u./ml) ( Figure 4 ). Lower Ad doses (ie 1 × 10 6 p.f.u./ml) were ineffective (data not Gene Therapy shown). Induction of HUVEC detachment required the presence of the ␤ cytoplasmic domain, since infection with the AdCMVCH2 control virus has no detectable effect even at the highest tested titer (1 × 10 8 p.f.u./ml) ( Figure 4 ). Also HUVEC infection with Ad vectors expressing ␤-gal or GFP did not result in cell detachment (data not shown). Next, we analyzed the kinetics of the de-adhesive effect. Confluent HUVEC monolayers were infected with 1 × 10 8 p.f.u./ml of AdCMVCH1 and their confluence assessed at 12, 18, 24 and 48 h after infection. The results from these experiments revealed that cells began to round up at 7-12 h after infection and started to detach after 12-15 h. After 24 h, 50-70% of the cells were detached from the substrate and more than 90% after 48 h (see Figure 5a ). Infection with AdCMVCH2 had no detectable effect on the HUVEC monolayer. Exposure of confluent HUVEC to AdTieCH1 and AdTieCH3 was also very effective in inducing cell detachment, but in comparison to the AdCMV constructs, the kinetics of detachment were slower. Cells started to detach 1-2 days after infection and more than 90% of the cells were detached after 5 days (Figure 5b ). Similarly to the infection with AdCMVCH2, infection with AdTieCH2 had no detectable effect on the HUVEC monolayer.
From these results, we conclude that Ad-mediated expression of the isolated cytoplasmic domain of the integrin ␤1 or ␤3 subunits in confluent HUVEC monolayers results in a time-and dose-dependent detachment of the cells from the substrate. Detached HUVEC die by apoptosis Culture of endothelial cells under conditions that prevent adhesion and spreading results in the onset of apoptosis, 31 a phenomenon also known as anoikis. 32 To test whether detachment of HUVEC from their substrate induced by the expression of the isolated ␤ cytoplasmic domains resulted in an increased rate of apoptosis, AdCMVCH1-and AdCMVCH2-infected HUVEC cultures were analyzed for their ability to bind annexin-V to their surface, a characteristic feature of apoptotic cells. 33 Only cells positive for annexin-V but negative for PI (propidium iodide) were considered apoptotic. Up to 12 h after infection with AdCMVCH1, there was no change in the number of annexin-V-binding cells (approximately 3 to 4%) as compared with untreated or AdCMVCH2-treated cultures. Starting 18-24 h after infection with AdCMVCH1 however, we observed an increase in the number of apoptotic cells compared with unexposed HUVEC or cells exposed to AdCMVCH2 (Figure 6a ). The proportion of annexin-V-binding cells further increased with time, and at 48 h after infection, when nearly all cells were detached, it reached 10% of the total cells. There was a linear relationship between the extent of cell detachment and relative amount of annexin-V-positive cells. The induction of apoptosis by the chimeric constructs was also confirmed using YoPro, a fluorescent dye that also stains early apoptotic cells. 34 Twenty-four hours after infection with AdCMVCH1 or AdCMVCH3, HUVEC cultures showed a three-to fourfolds increase in the YoPro fluorescence compared with non-infected or AdCMVCH2-infected cultures (Figure 6b) .
From these results, we conclude that AdCMVCH1-and AdCMVCH3-induced HUVEC detachment leads to apoptotic cell death.
Inhibition of integrin mediated HUVEC adhesion by the CH1 and CH3 chimeras
We next tested the effect of CH1 and CH3 expression on integrin-mediated HUVEC adhesion to the ECM proteins laminin, vitronectin, fibronectin and denatured collagen I (gelatin). HUVEC use ␤1 integrins to adhere to laminin (␣6␤1) and to fibronectin (␣5␤1), while they attach to vitronectin, denatured collagen I and fibronectin via ␣V␤3
23 (and our own data). In initial experiments con- fluent HUVEC were exposed to AdCMVCH1, AdCMVCH2, AdCMVCH3 and AdCMVLacZ for 48 h and detached cells were tested in adhesion experiments. Detached HUVEC completely failed to adhere to all ECM proteins tested with no differences between CH1 and CH3 constructs (data not shown). In order to exclude that lack of cell attachment was due to initiated apoptosis, adhesion tests were repeated using HUVEC collected after 16-18 h of exposure to the virus when cells begin to detach and have not yet detectable signs of apoptosis. At this early time point also, AdCMVCH1-and -CH3-infected cells (mix of attached and detached cells) failed to adhere on the tested ECM proteins, while AdCMVCH2-or AdCMVLacZ-infected cells efficiently re-adhered to the substrata (Figure 7a ). Throughout these experiments, the loss of adhesion was not specific for the isolated ␤ cytoplasmic domain expressed, ie expression of the ␤1 or ␤3 cytoplasmic domains (CH1 or CH3 chimeras, respectively) inhibited ␤1 and ␤3-dependent adhesion in a similar manner. The lack of specificity was further confirmed by performing adhesion tests on ␤ inte- Gene Therapy grin subunit-specific antibodies coated on plastic. Detached cells of both AdCMVCH1-and AdCMVCH3-infected cultures failed to adhere to immobilized monoclonal antibodies directed against ␤1 and ␣V␤3 integrins (Figure 7b) . Similar results were obtained using AdTie-infected cells. After 3 days of exposure, cells infected with AdTieCH1 or AdTieCH3 (mix of attached and detached cells) failed to adhere to vitronectin and denatured collagen, whereas they still partially adhered to fibronectin and laminin. A reduced adhesion of AdTieCH1 and AdTieCH3 to anti-␣v␤3 and -␤1 antibodies was observed (data not shown).
Taken together, these data demonstrate that expression of the CH1 or CH3 constructs results in a complete inhibition of ␤1 and ␤3 integrin-mediated HUVEC adhesion to ECM proteins. Loss of adhesion, however, was not specific for the ␤ cytoplasmic chimera expressed.
Regulation of cell surface integrins and LIBS expression by chimeric ␤ integrin constructs
In order to determine whether the cause of de-adhesion could be due to a loss of cell surface expression of endogenous integrins caused by the chimeric constructs, we measured the cell surface level of ␤1 integrins by staining with specific antibodies and FACS analysis. To this purpose we used three different ␤1-specific monoclonal antibodies: an inhibitory (LIA1/2), an activating (P4G11) and a non-function-perturbing (HB1.1) anti-␤1 monoclonal antibody. Infection with AdCMVCH1 did not induce a decrease in the cell surface expression of ␤1 integrins as compared with non-infected or AdCMVCH2-infected HUVEC neither 16 h (Figure 8a ) nor 48 h after infection (data not shown). Infection with AdCMVCH3 also had no effect on the cell surface level of ␤1 integrin expression (data not shown).
Cell surface integrins exist in graded degrees of ligand binding activity, and modulation of integrin ligand-binding activity is known to affect cell adhesion profoundly. 6 We therefore tested whether CH1 and CH3 chimeras might interfere with integrin ligand-binding function and thus disrupt or prevent HUVEC adhesion. To this purpose, we used a monoclonal antibody (HUTS-21) 35 that can discriminate between ligand-occupied and non-occupied ␤1 integrins by recognizing a unique ligand-induced binding site (LIBS). Non-infected, AdCMVCH1-, or AdCMVCH2-infected HUVEC were stained with mAb HUTS-21 in the absence or in the presence of a soluble integrin ligand (an RGD-containing peptide) or a control peptide (RGE). These experiments revealed that at 16 h after infection basal expression of the HUTS-21 epitope (ie expression in the absence of exogenous ligands) is diminished by approximately two-fold in cells expressing the CH1 chimera as compared to CH2-expressing cells (Figure 8b) . Addition of the integrin-binding peptide (RGD) enhanced expression of the LIBS epitope on AdCMVCH1-and AdCMVCH2-infected cells, as well as in non-infected cells. However, even in the presence of the RGD peptide, AdCMVCH1-infected cells expressed approximately two-fold less LIBS epitope as compared with AdCMVCH2-infected or non-infected control cells. The control peptide RGE had no or only minor effects on LIBS expression. At 48 h after infection, the level of inactivated integrin appears to be the same in cells expressing the CH1, or the CH2 chimera and in non- 
u./ml of AdCMV vectors. (a) Cell surface expression of different epitopes of ␤1 integrin subunit was estimated by FACS analysis. LIA1/2 and HB1.1 levels of cells exposed for 16 h to AdCMVCH1 (shaded), AdCMVCH2 (full line), non-infected HUVEC (dotted line) and background immunofluorescence (gray line) are shown. (b): HUTS expression (+/− RGD/RGE peptides) in HUVEC 16 h after infection with AdCMVCH1, with AdCMVCH2 and in non-infected HUVEC. (c) P4G11 levels (+/− RGD or RGE peptides) in AdCMVCH1-, AdCMVCH2-, and non-infected HUVEC 16 h after infection. AdCMVCH1 (shaded), AdCMVCH2 (full line), non-infected HUVEC (dotted line).
infected cells (data not shown). Importantly, the total expression of ␤1 integrins on these cells, as determined by staining with the P4G11 mAb, was the same on the three cell populations tested and was not altered by the RGD or RGE peptides (Figure 8c) . Similar results were obtained with AdCMVCH3-infected HUVEC (data not shown).
From these experiments, we conclude that the presence of the isolated cytoplasmic domain does not diminish ␤1 levels on the cell surface but decreases the expression of a ␤1 LIBS epitope, suggesting that loss of adhesion is not due to a lower amount of the integrin at the cell surface but rather to a reduced function. Since cells fail to adhere despite the presence of cell surface integrins, and the effect is not integrin-specific, we conclude that the constructs act through a trans-dominant negative effect on endogenous integrins.
The isolated ␤ cytoplasmic domain recruits to and disrupts focal adhesions The distribution of the chimeras on confluent HUVEC grown on denatured collagen was analyzed by immunofluorescence using monoclonal antibodies to the L3T4 receptor portion of the chimera. In AdCMVCH1-exposed cells, the construct localized at focal adhesions before the cell started rounding up and detaching (Figure 9f, arrow) . Focal L3T4 staining was lost in cells that already initiated detachment and the construct was observed within the cytoplasm (Figure 9f, arrowhead) . In the AdCMVCH2-infected cells there was no L3T4 staining in the focal adhesions, confirming that recruitment of the chimeric protein into focal adhesion required the presence of the cytoplasmic domain (Figure 9a ).
The effect of the CH1 chimera on focal adhesions and actin cytoskeleton, was further demonstrated by immunofluorescence staining of two components of focal adhesions, FAK (focal adhesion kinase) and paxillin and of polymerized actin. In control and AdCMVCH2-infected HUVEC, FAK and paxillin were present at focal adhesion sites and actin stress fibers were well developed and ended at focal adhesions (Figure 9b-d, arrows) . After exposure to AdCMVCH1, FAK was lost from focal adhesions and redistributed diffusely in the cytoplasm (Figure 9g, arrowhead) . Paxillin was also lost from focal adhesion and redistributed as dense patches (Figure 9h , arrowhead). The actin stress fibers were also completely disrupted and actin redistributed as dense patches, similarly to paxillin (Figure 9i, arrowhead) . Total phosphorylation at focal adhesion sites, as demonstrated by antiphosphotyrosine antibody staining, was also decreased in the CH1-expressing cells compared with control cells (Figure 9e , arrow, and k, arrowhead, respectively). To determine whether this decrease in phosphotyrosine content was due to a reduced phosphorylation of either FAK or paxillin (which contain most of the phosphotyrosine residues present in focal adhesions), we immunoprecipitated FAK and paxillin from lysates of cells exposed over 4 and 7 h to the different Ad and analyzed their degree of tyrosine phosphorylation by Western blotting using an anti-phosphotyrosine antibody. No significant diminution in phosphotyrosine content of either FAK or paxillin was observed (data not shown).
Taken together, these data demonstrate that expression of the CH-1 chimera results in the initial recruitment of CH1 to focal adhesion sites, followed by the disruption of focal adhesions and of the actin cytoskeleton.
Discussion
The purpose of this work was to evaluate the possibility of using a genetic approach to disrupt established monolayers of endothelial cells by interfering with integrinmediated cell adhesion. Here we report that: (1) adenovirus-mediated transfer of chimeric constructs containing 
u./ml of AdCMVCH2 (a-e) or AdCMVCH1 (f-k). After 7 h cells were fixed, permeabilized and stained for L3T4 (a,f), FAK (b,g), paxillin (c,h), actin (d,i) and phosphotyrosine residues (e,k). The CH1 chimera recruited at focal adhesions before the cell started rounding up and detaching (f, arrow), while it was diffusely distributed in the cytoplasm in cells that already started to detach (f, arrowhead). The CH2 chimera did not recruit at focal adhesions. In AdCMVCH1-infected cells, FAK redistributed from focal adhesion (b, arrow) into the cytoplasm (g, arrowhead). Paxillin redistributed from focal adhesion (c, arrow) into dense patches (h, arrowhead). Actin stress fibers (d, arrow) were completely disrupted and actin redistributed as dense patches (i, arrowhead). Total phosphotyrosine content at focal adhesions was also decreased in the CH1-expressing cells (k, arrowhead) compared with control cells (e, arrow).
the cytoplasmic and transmembrane domain of the ␤1 or ␤3 integrin subunit fused to the extracellular domain of L3T4 into confluent monolayers of HUVEC results in efficient expression of the chimeric proteins on the cell surface, and in a rapid and massive cell detachment due to the suppression of integrin-dependent adhesion; (2) the chimeric proteins disrupt focal adhesions and the Gene Therapy actin cytoskeleton, decrease integrin ligand-binding function, but do not alter cell surface integrin expression. The chimeric proteins exert their effect through a dominantnegative effect without specificity for a particular integrin ␤ subunit. The inhibition of integrin function, however, is not integrin specific (trans-dominant effect); (3) detached cells rapidly die by apoptosis. These results emphasize the potential of disrupting established endothelial cell adhesion by interfering with integrin function using a gene transfer approach.
Recombinant Ads were extremely efficient in infecting confluent HUVEC monolayers as more than 95% of the cells expressed the reporter gene. The percentage of infected cells and the level of transgene expression on the cell surface depended on the titers of the Ad used and on the time after infection. Maximal cell surface levels of the chimeric proteins were already observed 1 day (from the CMV promoter) or 3 days (from the Tie-1 promoter) after infection.
Cell detachment was clearly a dose-dependent effect. Maximal effects were obtained using 1 × 10 8 p.f.u./ml of Ad (MOI of approximately 500). Disruption of cell adhesion, however, was already observed at Ad doses of 6-12 × 10 8 p.f.u./ml (corresponding to a MOI of approximately 50), but not at lower doses (1 × 10 6 p.f.u./ml = 5 MOI), indicating that a threshold amount expression of the chimera is required for this effect. When tested in adhesion assays, cells expressing the CH1 or CH3 chimera failed to re-adhere to different proteins from the ECM, demonstrating that the chimeric constructs disrupted HUVEC attachment to the substrate by inhibiting integrin-mediated adhesion. The ␤ subunit cytoplasmic domain was essential to induce detachment, as infection with an Ad encoding for a construct without the cytoplasmic domain (ie the CH2 chimera), or infection with an Ad expressing an unrelated protein (ie AdCMVLacZ) did not cause cell detachment. This observation extends previous reports showing that overexpression of an isolated ␤ cytoplasmic domain results in a diminution in cell spreading, migration and ECM assembly, or in cell rounding and detachment. 25, 26, 28 HUVEC detachment and failure to re-adhere to ECM proteins was not related to a reduced cell surface expression of ␤1 or ␤3 integrins, indicating that the chimeric constructs did not inhibit adhesion by lowering integrin density at the cell surface but rather by impairing integrin function. Integrin-mediated cell adhesion is a highly regulated process that involves two distinct events. First, the binding of integrin extracellular domain to its ligand is driven by their affinity. The degree of affinity can be regulated from within the cell through conformational changes of the integrin ('inside-out' signaling). Second, ligated integrins cluster and recruit a number of cytoplasmic proteins to form focal adhesions and to reorganize the cytoskeleton (actin stress fiber formation), resulting in cell spreading and stable adhesion. Focal adhesions are essential for the initiation of signaling events, many of which are mediated by protein phosphorylation and are required for cell survival, proliferation and differentiation ('outside-in' signaling). 6 Importantly, both 'inside-out' and 'outside-in' signaling events involve interactions between the integrin ␤ cytoplasmic domain and cytoplasmic proteins. Our results indicate that the expression of isolated ␤1 and ␤3 cytoplasmic domains affects both events. ␤1 and ␤3 chimeras rapidly colocalized with integrins to focal adhesions and induced redistribution of the focal adhesion proteins FAK and paxillin, disrupted the actin cytoskeleton and induced a diminution in the phosphotyrosine content at focal adhesion sites, without, however, detectable changes in the phosphorylation of FAK and paxillin protein as revealed by immunoprecipitation and Western blotting analysis. This latter result suggests that the diminution in tyrosine phosphorylation seen by immunofluorescence staining was due to the disruption of focal adhesions and redistribution of FAK and paxillin, rather than to their decreased phosphorylation. None of those effects were induced by the control constructs lacking the ␤ cytoplasmic domain nor by Ad encoding the unrelated proteins ␤-gal or GFP. Since disruption of focal adhesions and the actin cytoskeleton preceded cell detachment, we conclude that these events were the cause rather then a consequence of HUVEC detachment. In addition, the ␤1 and ␤3 chimeras inhibited both the basal and the ligandinduced expression of a ␤1 LIBS epitope, indicating that these chimerae partially impaired the ligand-binding activity of ␤1 integrins, and confirming the proposed role of the cytoplasmic domain and its interactions with cytosolic/cytoskeletal proteins in determining the extracellular conformation and ligand-binding function of integrins. 36 The perturbing effect of the chimeras on focal adhesion formation of cytoskeleton organization, however, appears dominant over the effect on ligand-binding activity. This is suggested by the following observations. First, CH1-and CH3-expressing HUVEC failed to firmly adhere to substrate-immobilized anti-integrin antibodies, despite the fact that integrin binding to anti-integrin antibodies occurs independently of the affinity state of the integrin. Second, the decreased expression of the HUTS-21 LIBS epitope observed 16 h after infection was no longer detectable at 48 h, while cells were still unable to re-adhere to ECM proteins. Taken together these results indicate that expression of isolated ␤ cytoplasmic domain interferes with intracellular post-receptor events that are essential for inducing/maintaining stable cell adhesion. No specificity toward ␤1 or ␤3 integrins, however, was observed, indicating that the cytoplasmic domains exert a trans-dominant inhibition on integrin function. A comparable phenomenon has been reported with ␣ IIb ␤ 3 , ␤5 and ␤ 1 . 28, 37 This lack of specificity is likely due to the similarity in structure of the two cytoplasmic domains resulting in a competition for common or shared intracellular target molecules and has been referred to as trans-dominant negative effect. 37 Upon detachment, HUVEC rapidly died by apoptosis. Endothelial cell anoikis has been reported in the presence of integrin antagonists 19 or on non-adhesive substrates 31 but not when pre-existing cell adhesion was disrupted by expressing isolated integrin ␤ subunit cytoplasmic domains. Although isolated ␤ cytoplasmic domains can by themselves induce sustained tyrosine phosphorylation, 28 our data show that these signaling events are not sufficient to maintain non-adherent cells alive.
These results corroborate the notion that expression of isolated integrin ␤ subunit cytoplasmic domains inhibit endogenous integrin function, causing cells to detach and to die by apoptosis (anoikis). At this point, however, one major limitation for the use of these constructs in vivo is the lack of specificity towards specific integrins. To address this problem, we are generating new constructs that may take advantage of the recent progress made in the elucidation of the structure and function of the ␤3 cytoplasmic domain. In particular, two short domains (NPLY and NITY) have been identified to be essential for controlling the affinity state of ␤3 integrin. Deletions or mutations of these two domains, in particular of the tyrosine residues at position 747 and 759, cause loss of cell adhesion, migration, and integrin localization to focal adhesions, as well as decreased recruitment and activation of FAK. [38] [39] [40] Likewise, a point mutation of serine 752 inhibits 'inside-out' and 'outside-in' signaling. 41 Intracellular delivery of a peptide containing the NITY sequence was shown to inhibit ␣V␤3-but not ␤1-dependent cell adhesion. 42 Generation of recombinant proteins able to interfere selectively with the function of these essential residues on the ␤3 cytoplasmic domain may represent a crucial step toward the specific targeting and inactivation of integrin ␣V␤3.
In conclusion, we have shown that Ad-mediated transfer and expression in endothelial cells of constructs that inhibit endogenous integrin function results in the disruption of established cell monolayers. These results demonstrate the feasibility of disrupting cell adhesion through a genetic approach, and suggest that such a strategy may represent an alternative to the use of function blocking anti-integrin antibodies or antagonistic peptides. However, before this approach can be tested in vivo for its capacity to disrupt tumor vessels selectively, new constructs which specifically target individual integrins, in particular ␣V␤3, need to be developed. Human umbilical vein endothelial cells (HUVEC) were prepared as described 23 and used for experiments between passages 3 and 7. HUVEC were cultured in EBM medium (Clonetics Walkersville, MA, USA) supplemented with 10% FCS (Seromed, Berlin, Germany), 12 g/ml of bovine brain extract (Clonetics), 10 ng/ml recombinant EGF (Genzyme, Cambridge, MA, USA), 25 U/ml heparin, 1 g/ml hydrocortisone (Sigma Chemie), 2 mm l-glutamine, 100 g/ml streptomycin and 100 U/ml penicillin (Life Technologies).
Material and methods
Non-endothelial cell lines: HT-29, was derived from a colon adenocarcinoma (ATCC HTB 38); Me235 and Me315 were melanoma cell lines established from metastases by Dr D Rimoldi, Ludwig Institute for Cancer Research, Lausanne Branch).
Construction of recombinant Ad. AdCMV constructs Three constructs were produced: CH1, CH2 and CH3. CH1 is composed of residues 733-799 of ␤1 integrin (cytoplasmic and transmembrane domains) fused to the extracellular domain of the L3T4 molecule. CH2 consists of the extracellular domain of the L3T4 molecule, the transmembrane domain of ␤1 followed by a stop codon at residue 754 and serves as control. CH1 and CH2 were gifts from M Lukashev, UCSF San Francisco, USA. 28 The two genes were placed under the control of the CMV promoter in the pCEP4 plasmid. CH3 contains a 219 bp cDNA fragment of the ␤3 cytoplasmic and transmembrane domains. The ␤3 cDNA was generated by PCR using MeWO cells cDNA as template and was fused with L3T4 extracellular fragment by PCR extension. PCR fragments were cloned into pCR II (Invitrogen, San Diego, CA, USA) and the sequence of the constructs was verified by nucleotide sequencing (Automated Sequencing Facility, ISREC, Epalinges, Switzerland).
CMVCH1, CMVCH2 and CMVCH3 were constructed by subcloning the XbaI-XhoI fragment (XhoI-SpeI for CMVCH3) of CH1, CH2, CH3 plasmids into NheI-XhoI (XhoI-XbaI) of pCI-neo (Promega, Madison, WI, USA). Shuttle plasmids were constructed by subcloning the BglII-FspI fragment into BamHI-HpaI of pXC15#18, a shuttle plasmid containing Ad-5 sequences (derived from pXC generated by J Schaack). 44 AdCMVCH1, -CH2, -CH3 constructs were generated by homologous recombination between JM17, a plasmid containing an Ad type-5 dl309 backbone with deletions of E1 and partial deletions of E3 regions, and pXC15#18, a shuttle plasmid containing the sequence of interest (CH1, CH2 and CH3), into 293 cells using calcium phosphate precipitation for transfection of DNA. 44 Homologous recombination between the two plasmids resulted in the production of recombinant Ad expressing the different truncated integrins.
Gene Therapy
AdTie constructs
In order to restrict expression to endothelial cells only, ␤1 and ␤3 truncated integrins were placed under the control of the human Tie-1 promoter region (1-866) known to be specific for endothelial cells. 29, 30 AdTieCH1, AdTieCH2, AdTieCH3 were constructed by replacing the CMV promoter (BglII-PpoI) by a PCR-amplified Tie-1 promoter DNA (866 bp). Individual clones isolated from the initial virus pool were isolated, purified as described 45 and tested for the presence of the promoter and insert DNA by Southern blotting hybridization using a 32 P-labeled L3T4 or Tie-1 promoter cDNA generated by a random-priming kit (Roche Diagnostics, Rotkreuz, Switzerland). Large-scale concentrated stocks were produced from single clones, purified by CsCl gradient centrifugation and titrated by plaque assays. The activity of the constructs was verified by analyzing the expression of the fusion proteins by staining infected HUVEC with an antibody against L3T4 and subsequent FACS analysis. AdCMVLacZ and AdCMVGFP were generously provided by Drs D Reed and V Jongeneel (Ludwig Institute for Cancer Research, Lausanne Branch) and Dr R Iggo (ISREC), respectively.
Infection of cells with Ad
Cells were seeded and left to grow till confluence (about 2 days) before being infected with the different Ad at the concentration mentioned. Unless otherwise stated, the concentrated Ad was added directly to the media at a multiplicity of infection (MOI) of approximately 500 and exposed to virus for 2 to 5 days. At given times, cells were observed under the microscope and photographed (Zeiss, Switzerland), harvested and used for cell surface staining and FACS analysis or adhesion tests.
Cell staining and FACS analysis
For detection of L3T4 and cell surface integrins expression, cells were trypsinized with trypsin-EDTA, rinsed and incubated with specific antibodies in PBS/1% FCS followed by FITC-conjugated goat anti-rat immunoglobulin. For assessment of viability, recovered cells were incubated with propidium iodide (PI; 10 g/ml, Sigma Chemie) and immediately analyzed on a FACScan II (Becton Dickinson, Mountain View, CA, USA). Viable cells exclude PI, while dead cells stain PI positive. Analysis was done on viable cells only. The effect of chimera on the expression of HUTS-21 epitope was examined by FACS analysis. Confluent HUVEC were exposed to 1 × 10 8 p.f.u./ml of virus for 16 h or 48 h. Supernatant and attached cells were harvested, washed twice with RPMI medium without FCS and incubated with 10 mm RGD or RGE peptides (Sigma Chemie) and HUTS-21 antibody during 20 min at 37°C in RPMI containing 0.1% BSA. The cells were washed, incubated with FITC-conjugated goat anti-mouse immunoglobulin and double stained by incubation with a PE-conjugated rat anti-L3T4.
Detection of apoptosis HUVEC were collected, washed with PBS and incubated in the presence of annexin-V-FITC and PI (Annexin V apoptosis detection kit, R&D Systems, Abingdon, UK) following manufacturer's protocol, and analyzed by FACS. Cells positive for annexin-V staining and negative for PI staining were considered as apoptotic. Alternatively, HUVEC apoptosis was quantified by staining the cells with the dye YoPro (Molecular Probes, Eugene, OR, USA) as reported. 34 YoPro was added to HUVEC cultures (0.5 m, final concentration) and incubated for 15 min at 37°C. Thereafter cells were collected, resuspended in 100 l fresh YoPro-containing medium and transferred into a microtiter plate. Florescence was measured using a fluorimeter (exc: 485 nm/em: 530 nm) (Fluoro Count, Packard Instrument, Meriden, CT, USA). Results are given as mean values of duplicate determinations ± s.d.
Adhesion assay
Adhesion assays were performed as previously described. 23 Briefly, 96-well plates (Maxisorp; NUNC, Roskilde, Denmark) were coated with 1 g per well of ECM proteins or anti-integrin antibodies overnight at 37°C in PBS + with Ca Immunofluorescence staining Cells (1.5 × 10 5 were grown overnight on 18-mm circular glass coverslips coated with 0.5% gelatin in 12-well plates. Cells were exposed to 1 × 10 8 p.f.u./ml of virus for 7 h and fixed in 4% paraformaldehyde for 10 min at room temperature. Cells were washed and permeabilized with 0.1% Triton X-100 in PBS for 4 min at room temperature. Nonspecific binding was blocked by incubation in 1% BSA for 10 min. For immunofluorescence staining, the slides were incubated with the primary antibodies in 0.1% BSA (anti-paxillin, anti-FAK, anti-Pi-Y or anti-L3T4), washed three times with PBS, followed by an incubation with Cy3-conjugated goat anti-mouse or anti-rabbit immunoglobulin in 0.1% BSA. For actin staining, FITCphalloidin was used. The slides were mounted in MOWIOL (Hoechst, Frankfurt/Main, Germany) and viewed by epifluorescence microscopy with a 63× oil immersion objective and photographs were taken (CCD camera; Photonic Science, Milham, UK).
